|
|
Volumn 58, Issue 4, 2001, Pages 285-288
|
|
FDA approves nateglinide for treatment of type 2 diabetes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DICLOFENAC;
DIGOXIN;
GLIBENCLAMIDE;
METFORMIN;
NATEGLINIDE;
PHENYTOIN;
PROPRANOLOL;
TOLBUTAMIDE;
WARFARIN;
CLINICAL TRIAL;
DOSE KIDNEY FUNCTION RELATION;
DOSE LIVER FUNCTION RELATION;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PRIORITY JOURNAL;
|
|
EID: 0035865805
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/58.4.285 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|